US Patent Issued to Merck Sharp & Dohme on July 15 for "Methods for treating cancer with anti-PD-1 antibodies" (New York, New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,984, issued on July 15, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Methods for treating cancer with anti-PD-1 antibodies" was invented by Mallika Lala (West New York, N.Y.), Lokesh Jain (Edison, N.J.) and Mengyao Li (Springfield, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for treating cancer in a patient comprising administering a PD-1 antagonist, e.g., an anti-PD-1 antibody or antigen binding fragment thereof (e.g. pembrolizumab), in specific amounts to the patient about every six weeks. In some embodiments, the amount of anti-PD-1 antibody or antigen binding fragment thereof is about ...